ERBB2 and breast cancer: Triple-negative BC, a subtype of BC, is characterized by high invasiveness, a propensity for recurrence and metastasis, and the absence of estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptor-2 (HER-2) expression.